Treatment of aggressive rheumatoid arthritis in adults with combination of gold thiomalate, methotrexate and chloroquine with intermittent parenteral depot-methylprednisolone in tapering dose in early stage while avoiding use of non-steroidal anti-inflammatory drugs

A. N. Malaviya, A. Kumar, R. Muralidhar, Ira Pande, H. S. Meena, Veena D Taneja, N. K. Mehra

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

34 adult patients with aggressive rheumatoid arthritis (RA) were selected with an intent-to-treat with a combination of gold thiomalate (GTM), methotrexate (Mtx) and chloroquine (CQ) with intramuscular depot-methylprednisolone (IM-MP) in a tapering weekly dose. Non-steroidal anti-inflammatory drugs (NSAIDs) were not given to these patients. Paracetamol or dextropropoxiphene were given only in those where pain was not controlled with IM-MP. 9 (26.5%) patients dropped out after the first visit due to non-medical (mostly domestic) reasons. All of them were traced and found alive taking some form of irregular treatment Of the remaining 25 patients who completed 1 year follow-up, 3 (12%) could not continue the same regimen due to skin rash requiring change of medicine. Another 5 (20%) patients developed mouth ulceration which was minor and which subsided without discontinuation of the medicines. No life-threatening adverse effects were seen in any patient. Of the 22 patients completing the trial 13 (59%) responded with improvement in inflammatory synovitis, 3 (13.5%) of whom achieved complete remission. 9 (41%) patients did not show significant improvement but still continued the follow up.

Original languageEnglish (US)
Pages (from-to)521-525
Number of pages5
JournalJournal of Association of Physicians of India
Volume45
Issue number7
StatePublished - Jul 1997

Fingerprint

Gold Sodium Thiomalate
Methylprednisolone
Chloroquine
Methotrexate
Rheumatoid Arthritis
Anti-Inflammatory Agents
Pharmaceutical Preparations
Therapeutics
Synovitis
Acetaminophen
Exanthema
Mouth
Medicine
Pain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{e7a32a478dd44e179f449ef67ab6b53b,
title = "Treatment of aggressive rheumatoid arthritis in adults with combination of gold thiomalate, methotrexate and chloroquine with intermittent parenteral depot-methylprednisolone in tapering dose in early stage while avoiding use of non-steroidal anti-inflammatory drugs",
abstract = "34 adult patients with aggressive rheumatoid arthritis (RA) were selected with an intent-to-treat with a combination of gold thiomalate (GTM), methotrexate (Mtx) and chloroquine (CQ) with intramuscular depot-methylprednisolone (IM-MP) in a tapering weekly dose. Non-steroidal anti-inflammatory drugs (NSAIDs) were not given to these patients. Paracetamol or dextropropoxiphene were given only in those where pain was not controlled with IM-MP. 9 (26.5{\%}) patients dropped out after the first visit due to non-medical (mostly domestic) reasons. All of them were traced and found alive taking some form of irregular treatment Of the remaining 25 patients who completed 1 year follow-up, 3 (12{\%}) could not continue the same regimen due to skin rash requiring change of medicine. Another 5 (20{\%}) patients developed mouth ulceration which was minor and which subsided without discontinuation of the medicines. No life-threatening adverse effects were seen in any patient. Of the 22 patients completing the trial 13 (59{\%}) responded with improvement in inflammatory synovitis, 3 (13.5{\%}) of whom achieved complete remission. 9 (41{\%}) patients did not show significant improvement but still continued the follow up.",
author = "Malaviya, {A. N.} and A. Kumar and R. Muralidhar and Ira Pande and Meena, {H. S.} and Taneja, {Veena D} and Mehra, {N. K.}",
year = "1997",
month = "7",
language = "English (US)",
volume = "45",
pages = "521--525",
journal = "Journal of Association of Physicians of India",
issn = "0004-5772",
publisher = "Journal of Association of Physicians of India",
number = "7",

}

TY - JOUR

T1 - Treatment of aggressive rheumatoid arthritis in adults with combination of gold thiomalate, methotrexate and chloroquine with intermittent parenteral depot-methylprednisolone in tapering dose in early stage while avoiding use of non-steroidal anti-inflammatory drugs

AU - Malaviya, A. N.

AU - Kumar, A.

AU - Muralidhar, R.

AU - Pande, Ira

AU - Meena, H. S.

AU - Taneja, Veena D

AU - Mehra, N. K.

PY - 1997/7

Y1 - 1997/7

N2 - 34 adult patients with aggressive rheumatoid arthritis (RA) were selected with an intent-to-treat with a combination of gold thiomalate (GTM), methotrexate (Mtx) and chloroquine (CQ) with intramuscular depot-methylprednisolone (IM-MP) in a tapering weekly dose. Non-steroidal anti-inflammatory drugs (NSAIDs) were not given to these patients. Paracetamol or dextropropoxiphene were given only in those where pain was not controlled with IM-MP. 9 (26.5%) patients dropped out after the first visit due to non-medical (mostly domestic) reasons. All of them were traced and found alive taking some form of irregular treatment Of the remaining 25 patients who completed 1 year follow-up, 3 (12%) could not continue the same regimen due to skin rash requiring change of medicine. Another 5 (20%) patients developed mouth ulceration which was minor and which subsided without discontinuation of the medicines. No life-threatening adverse effects were seen in any patient. Of the 22 patients completing the trial 13 (59%) responded with improvement in inflammatory synovitis, 3 (13.5%) of whom achieved complete remission. 9 (41%) patients did not show significant improvement but still continued the follow up.

AB - 34 adult patients with aggressive rheumatoid arthritis (RA) were selected with an intent-to-treat with a combination of gold thiomalate (GTM), methotrexate (Mtx) and chloroquine (CQ) with intramuscular depot-methylprednisolone (IM-MP) in a tapering weekly dose. Non-steroidal anti-inflammatory drugs (NSAIDs) were not given to these patients. Paracetamol or dextropropoxiphene were given only in those where pain was not controlled with IM-MP. 9 (26.5%) patients dropped out after the first visit due to non-medical (mostly domestic) reasons. All of them were traced and found alive taking some form of irregular treatment Of the remaining 25 patients who completed 1 year follow-up, 3 (12%) could not continue the same regimen due to skin rash requiring change of medicine. Another 5 (20%) patients developed mouth ulceration which was minor and which subsided without discontinuation of the medicines. No life-threatening adverse effects were seen in any patient. Of the 22 patients completing the trial 13 (59%) responded with improvement in inflammatory synovitis, 3 (13.5%) of whom achieved complete remission. 9 (41%) patients did not show significant improvement but still continued the follow up.

UR - http://www.scopus.com/inward/record.url?scp=0041639172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041639172&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0041639172

VL - 45

SP - 521

EP - 525

JO - Journal of Association of Physicians of India

JF - Journal of Association of Physicians of India

SN - 0004-5772

IS - 7

ER -